Evidence map›Paper›PMID 42292188›Full record

SynthesisFrontiers in medicine2026

Aesthetic techniques for melanocytic nevus management: clinical outcomes, cosmetic satisfaction, and safety-a systematic review and meta-analysis.

Zhong Guo, Chuanying Wang

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zhong GuoDepartment of Medical Aesthetic, Huai'an Maternal and Child Health Care Hospital Affiliated to Yangzhou University, Huai'an, Jiangsu, China.
Chuanying WangDepartment of Medical Aesthetic, Huai'an Maternal and Child Health Care Hospital Affiliated to Yangzhou University, Huai'an, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Melanocytic nevi are among the most frequently treated lesions in aesthetic dermatology. Various techniques are used for cosmetic or diagnostic purposes. However, comparative evidence regarding treatment efficacy, recurrence risk, cosmetic outcomes, and safety remains inconsistent. Objective: To systematically evaluate and compare clinical clearance, recurrence rates, cosmetic outcomes, and adverse events associated with aesthetic techniques used for the removal of melanocytic nevi. Methods: A systematic search of PubMed, Scopus, Web of Science, ScienceDirect, Wiley, and Google Scholar was conducted for studies published between January 2000 and May 2025. Studies reporting outcomes of surgical or aesthetic interventions for benign melanocytic nevi were included. Data extraction followed PRISMA 2020 guidelines. A random-effects meta-analysis was performed to pool estimates of clinical clearance, recurrence, and cosmetic satisfaction. Subgroup analyses were conducted according to nevus subtype (junctional vs. intradermal) and treatment modality. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool for randomized trials and the Newcastle-Ottawa Scale for observational studies. Results: A total of 46 studies involving 4,201 lesions were included. Surgical excision demonstrated the highest clinical clearance rate (96.4%; 95% CI 92.1-99.2) and the lowest recurrence rate (2.1%). Laser-based treatments produced the most favorable cosmetic outcomes, with Er:YAG laser achieving the highest satisfaction score (8.8/10), followed by CO Conclusion: Surgical excision remains the most reliable method for complete melanocytic nevus removal and histopathologic assessment but may yield less favorable cosmetic outcomes. Laser-based treatments, particularly Er:YAG and CO

Indexed as

aesthetic dermatologycosmetic outcomeslaser ablationmelanocytic nevussurgical excisionsystematic review

Identifiers

PMID42292188
PMCPMC13261504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.